16S rRNA sequencing of mouse fecal microbiota from different experimental groups
This project involves the 16S rRNA sequencing of fecal microbiota from mice across 12 different experimental groups. The groups consist of control mice (control1, control2, control3), J-treated(lactobacillus treatment) mice (J-1, J-2, J-3), KSS-treated(antibiotic treatment) mice (KSS-1, KSS-2, KSS-3), and combined K+J treatment groups (K+J-1, K+J-2, K+J-3). This study explores the impact of cholesterol on tumor growth and the potential therapeutic effects of Lactobacillus and Simvastatin.